A quick sell off to about 38 could be just what it needs to bring buyers back in. Id rather see a huge run to 50 first but don't see it. I will wait and see what the flow tests bring us.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
